Navigation Links
Techne Corporation Announces Acquisition
Date:5/3/2011

MINNEAPOLIS, May 3, 2011 /PRNewswire/ -- Techne Corporation (NASDAQ: TECH) (Techne) announced today that it has acquired 100% ownership of Tocris Holdings Limited and subsidiaries (Tocris), a leading supplier of reagents for non-clinical life science research.  Tocris' products are used in both in-vitro and in-vivo experiments, to understand biological processes and diseases. The business is focused on making biologically active neuro- and bio-chemicals which are used by researchers to elucidate biological processes and pathways. The products are used in life-science research activities and as part of the initial drug discovery process.

Techne, through its subsidiaries, R&D Systems, Inc. and R&D Systems Europe, Ltd., is a leading developer, manufacturer and distributor of purified cytokines (proteins), antibodies and assay kits which are sold to biomedical researchers and clinical research laboratories.

Tocris is a Bristol, UK based company with origins deriving from Tocris Neuramin and Cookson Chemical which were founded in 1982 and 1985, respectively. Tocris currently offers over 2,900 chemical, peptide and antibody products. The principal end users are non-clinical laboratory based researchers, working in areas such as neuroscience, cardiovascular disease, endocrinology and cellular processes. Originally a supplier of small molecules, Tocris has successfully pursued a strategy of extending its product range into related market segments such as signal transduction.  The products sold by Tocris are used in various research fields including cancer, cardiovascular disease, endocrinology, immunology, metabolic diseases, neurological diseases, pain and inflammation, and respiratory diseases. From a cellular process perspective, Tocris products are used to study angiogenesis, apoptosis, cell cycle, cell metabolism, cellular skeleton and motor proteins, ex
'/>"/>

SOURCE Techne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Techne Corporation Announces Acquisition
2. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
3. Techne Corporation Announces That Dr. Roeland Nusse Has Accepted a Seat on Its Board of Directors
4. Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010
5. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
6. Techne Corporation Declares Dividend
7. TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
8. Techne Corporation Board Member Recognized
9. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
10. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
11. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... DC (PRWEB) January 14, 2014 Carahsoft ... for Thursday, January 23, 2014 at 2pm EST (11am ... Knowledge.” The topic focuses on how technology can turn ... critical decisions for government agencies. The online webinar will ...
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... ITMN ) today announced that Dan Welch, President ... Bank of America 2008,Health Care Conference in Las Vegas ... EDT)., To access a live audio webcast of ... to the investor relations page of InterMune,s,corporate website at ...
... Mass., May 9 Inverness Medical,Innovations (Amex: ... previously announced,acquisition of Matria Healthcare, Inc. was ... of business today, May 9, 2008. Matria,headquartered ... services particularly in the areas of women,s ...
... ... earnings growth., ST. DAVID,S, Bermuda, May 9 ... quarter ended,March 31, 2008. Revenue in the quarter ended March 31, 2008 ... primary,drivers of the increase in revenue were the net sales of our ...
Cached Biology Technology:Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc. 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17
(Date:4/20/2014)... pancreatic cancers also promote drug-resistance and ultimately spur tumor ... School of Medicine have discovered a molecule, or biomarker, ... appears responsible for inducing tumor metastasis by enhancing the ... findings, published in the April 20, 2014 online issue ... new therapeutic opportunities for reversing drug resistance in a ...
(Date:4/18/2014)... of emergency contraceptive pills in Peru found that ... of substandard quality or falsified. Many pills released ... wrong active ingredient. One batch had no active ... fake drugs, researchers at the Georgia Institute of ... to quickly assess suspected counterfeit drugs and then ...
(Date:4/18/2014)... DNA adds a twist to the story of how barnyard ... April 21 in the journal Proceedings of the National ... of chickens that lived 200-2300 years ago in Europe, researchers ... may have looked far different from the chickens we know ... we associate with modern domestic chickens -- such as their ...
Breaking Biology News(10 mins):Cancer stem cells linked to drug resistance 2Counterfeit contraceptives found in South America 2Counterfeit contraceptives found in South America 3Ancient DNA offers clues to how barnyard chickens came to be 2
... funded by the Government of Canada, today announced $100,000 ... income countries worldwide to pursue bold, creative ideas to ... also announced for 17 Canadian-based projects to be implemented ... will mimic rocket technology to propel coagulant nanoparticles into ...
... is living in your gut, and what they,re doing? The ... our own cells by as many as 10 to 1 ... the food we eat this Thanksgiving to building up our ... researchers at the University of Colorado Boulder along with researchers ...
... The days of researching cell behavior by using the ... fluorescence microscopes have gone. Microscopy has now reached the ... mathematics, and a new field is emerging at the ... how scientists study fundamental questions of cell behavior. ...
Cached Biology News:Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 2Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 3Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 4Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 5Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 6Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 7Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 8Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 9Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 10Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 11Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 12New public gut bacteria study expected to reach around world 2New public gut bacteria study expected to reach around world 3New public gut bacteria study expected to reach around world 4A multidisciplinary approach and a new field help to understand cell behavior 2
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
... 100 g of monoclonal antibody reactive against ... of SURF1 are highest in growing cultured cells. ... c oxidase which is thought to participate in ... insertion into this subunit. Mutations of SURF1, particularly ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Biology Products: